Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 09 symbols : Pfe save search
Achieve Reports Financial Results for Third Quarter 2021 and Provides Update on Cytisinicline Development
Published: 2021-11-09 (Crawled : 22:00) - achievelifesciences.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -1.76%
H: 3.82%
C: 3.42%
ACHV | $4.51 -1.31% -1.33% 35K
|
Health Technology
|
| O: -0.36%
H: 5.73%
C: -1.57%
financial results results
M-Star Simulations & Pfizer Offer Advanced Modeling Strategies To Accelerate Vaccine Development, Scale-up & Tech Transfer
Published: 2021-11-09 (Crawled : 15:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
vaccine
Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States
Published: 2021-11-09 (Crawled : 13:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
BHVN 1 d | $38.99 -7.52% 0.0% 3.4M
|
Health Technology
|
| O: -20.3%
H: 0.0%
C: 0.0%
commercialization collaboration
Anti-Vascular Endothelial Growth Factor Therapeutics Market Size Worth $12.82 Billion By 2028: Grand View Research, Inc.
Published: 2021-11-09 (Crawled : 10:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
growth research
Alentis Therapeutics Announces Appointments of Luca Santarelli to the Board of Directors and Rafaèle Tordjman as Chairperson
Published: 2021-11-09 (Crawled : 10:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.